Multiple sclerosis is hypothesized to be a cell-mediated autoimmune di
sease directed against central nervous system myelin. Immunotherapy is
directed at decreasing the autoimmune response using both specific an
d nonspecific modulation of the immune system in an attempt to halt ac
cumulation of disability. Symptomatic therapy may also help multiple s
clerosis patients.